Financials

News Discussions Technicals Seasonals

4891 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

TMS Co., Ltd. engages in the research and development of pharmaceutical products and medical devices. It focuses on a family of compounds called Stachybotrys microspora triprenyl phenol (SMTPs). The company was founded by Keiji Hasumi on February 17, 2005 and is headquartered in Tokyo, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

4891 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company